Literature DB >> 10399102

Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy.

D Seripa1, C Gravina, R Volpe, M Margaglione, S Papa, G Merla, P Parrella, G Di Minno, G Ricci, M Testa, V M Fazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10399102     DOI： 10.1023/a:1005550601952

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Familial defective apo B-100, characterization of an Italian family.

Authors:  A Corsini; B J McCarthy; A Granata; L F Soria; S Fantappiè; C Romano; L Romano; R Fumagalli; A L Catapano
Journal:  Eur J Clin Invest       Date:  1991-08       Impact factor: 4.686

2.  Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.

Authors:  A Tybjaerg-Hansen; R Steffensen; H Meinertz; P Schnohr; B G Nordestgaard
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

3.  Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.

Authors:  J C Defesche; K L Pricker; M R Hayden; B E van der Ende; J J Kastelein
Journal:  Arch Intern Med       Date:  1993-10-25

4.  Incidence of the apolipoprotein B-3500 mutation in Denmark.

Authors:  P S Hansen; B Nørgaard-Petersen; H Meinertz; H K Jensen; A B Hansen; I C Klausen; L U Gerdes; O Faergeman
Journal:  Clin Chim Acta       Date:  1994-10-14       Impact factor: 3.786
  4 in total
  1 in total

Review 1.  ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature.

Authors:  Amira S Sabbagh; Rose T Daher; Zaher K Otrock; Rabab N Abdel Khalek; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2006-12-08       Impact factor: 2.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.